Skip to content

Clinical trials

Completed Phase 2 Disease Progression trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Progression Phase: Phase 2 Status: Completed Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20062
20071
20082
20091
20112
20121
20132
20191
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AGC Biologics S.p.A.2
National Cancer Institute (NCI)2
ARCAGY/ GINECO GROUP1
Assistance Publique - Hôpitaux de Paris1
Centre Leon Berard1
Institute for Neurodegenerative Disorders1
Janssen-Cilag International NV1
Lisata Therapeutics, Inc.1
M.D. Anderson Cancer Center1
Medical Mission Institute, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease Progression16
Neoplasm Metastasis3
Ovarian Neoplasms3
Brain Neoplasms2
Glioma2
Parkinson Disease2
Recurrence2
Acquired Immunodeficiency Syndrome1
Astrocytoma1
Autoimmune Diseases of the Nervous System1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.